PerkinElmer Appoints President & Chief Operating Officer
December 10 2018 - 8:00AM
Business Wire
Promotes Prahlad Singh to lead newly created
role
PerkinElmer, Inc. (NYSE:PKI), a global leader committed to
innovating for a healthier world, today announced that its board of
directors has named Prahlad Singh president and chief operating
officer, effective January 1, 2019. In his expanded position, Dr.
Singh will have responsibility for both the Discovery and
Analytical Solutions (DAS) and Diagnostics operating divisions of
the Company. This change is being made to better facilitate
synergies across the businesses to identify incremental growth
opportunities, create operating efficiencies, and most importantly,
accelerate the pace of innovation across the Company. Dr. Singh,
along with the leaders of the Company’s corporate functions, will
continue to report to Robert F. Friel, PerkinElmer’s chairman and
chief executive officer.
“It is clear that technologies, applications, and customer needs
are converging across DAS and Diagnostics as our customers’
businesses evolve and the lines between therapeutics, diagnostics,
food, and digital health are intersecting,” said Friel. “The
opportunities for DAS to become an enabler of the sciences of
Diagnostics, and vice-versa, continue to grow. Prahlad’s track
record of consistently driving strong results operationally,
commercially and strategically makes him well qualified to take on
this important role. I look forward to working with him as he helps
both the Diagnostics and DAS businesses better innovate
breakthrough solutions and exceptionally serve our customers,
ultimately driving greater value across our markets.”
Dr. Singh joined PerkinElmer in 2014 as president of the
Diagnostics business. He was elected an officer of PerkinElmer in
2016 and executive vice president in March 2018. Dr. Singh served
as general manager of GE Healthcare’s Women’s Health Business,
responsible for the mammography and bone densitometry businesses.
Before that, Dr. Singh held senior executive level roles in
strategy, business development and M&A at both GE and Philips
Healthcare. From 1995 to 2007, he held leadership roles of
increasing responsibility at DuPont Pharmaceuticals and
subsequently Bristol Myers Squibb Medical Imaging which included
managing the Asia Pacific and Middle East regions.
About PerkinElmer
PerkinElmer, Inc. is a global leader focused on innovating for a
healthier world. The Company reported revenue of approximately $2.3
billion in 2017, has about 11,000 employees serving customers in
more than 150 countries, and is a component of the S&P 500
Index. Additional information is available through 1-877-PKI-NYSE,
or at www.perkinelmer.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181210005183/en/
Investor RelationsTommy J. Thomas,
781-663-5889tommy.thomas@perkinelmer.comMedia RelationsBrian
Willinsky, 781-663-5728brian.willinsky@perkinelmer.com
PerkinElmer (NYSE:PKI)
Historical Stock Chart
From Mar 2024 to Apr 2024
PerkinElmer (NYSE:PKI)
Historical Stock Chart
From Apr 2023 to Apr 2024